New eye drops take on dry eye in Head-to-Head trial
NCT ID NCT06388070
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tested whether a new eye drop called HUC3-053 works as well as an existing drop (Hyalein) for dry eye. 297 adults used the drops 5-6 times daily for 12 weeks. The study measured changes in eye surface staining and other signs of dry eye.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HUC3-053 eye drops (0.3% hyaluronic acid)
- What this could lead to
- If it works, this could offer a new option for relieving dry eye symptoms, similar to existing hyaluronic acid drops.
- What could go wrong
- This is a non-inferiority trial, meaning it aims to show HUC3-053 is as good as, not better than, an existing treatment. Even if successful, it may not offer additional benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE SYNDROMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gangbuk Samsung Hospital
Seoul, Jongno-gu, 03181, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your own blood cure dry eye? plasma drops put to the test
- New eye drops could bring relief to millions with chronic dry eye
- Eye rinse device aims to soothe dry eye pain
- Supplement shows promise for dry eye sufferers in new study
- Which eye drop stings less? small study pits flarex against lotemax SM
- Can radio waves zap dry eye away? new trial tests device for stubborn cases